Luc Brunsveld

Since my PhD in supramolecular chemistry in 2001, I have focused on the modulation protein-protein interactions for diverse biomedical applications. Our group is internationally recognized for its unique work on the stabilization of protein-protein interactions and for delineating the underlying concepts such as cooperativity and multivalency. I am the recipient of the Sofja Kovalevskaja Award, ERC and VICI grants and have been awarded the Golden Medal of the KNCV, NVBMB Award, and KNAW membership. Our team is highly active in translating research results through the biotech start-up Ambagon Therapeutics (https://ambagontx.com/).